Calvin Santiago1, Nathan Herrmann2, Walter Swardfager3, Mahwesh Saleem1, Paul I Oh4, Sandra E Black5, Krista L Lanctôt6. 1. Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada; Neuropsychopharmacology Research Group, Sunnybrook Research Institute, Toronto, Ontario, Canada. 2. Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada; Neuropsychopharmacology Research Group, Sunnybrook Research Institute, Toronto, Ontario, Canada; Canadian Partnership for Stroke Recovery, Sunnybrook Research Institute, Toronto, Ontario, Canada. 3. Neuropsychopharmacology Research Group, Sunnybrook Research Institute, Toronto, Ontario, Canada; Canadian Partnership for Stroke Recovery, Sunnybrook Research Institute, Toronto, Ontario, Canada. 4. Toronto Rehabilitation Institute, Toronto, Ontario, Canada. 5. Canadian Partnership for Stroke Recovery, Sunnybrook Research Institute, Toronto, Ontario, Canada; Department of Medicine (Neurology), Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, and University of Toronto, Toronto, Ontario, Canada; Brain Sciences Research Program, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, and University of Toronto, Toronto, Ontario, Canada. 6. Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada; Neuropsychopharmacology Research Group, Sunnybrook Research Institute, Toronto, Ontario, Canada; Canadian Partnership for Stroke Recovery, Sunnybrook Research Institute, Toronto, Ontario, Canada; Toronto Rehabilitation Institute, Toronto, Ontario, Canada; Brain Sciences Research Program, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, and University of Toronto, Toronto, Ontario, Canada. Electronic address: krista.lanctot@sunnybrook.ca.
Abstract
OBJECTIVE: Coronary artery disease (CAD) is associated with an increased risk of cognitive decline. Although cerebral white matter (WM) damage predicts cognitive function in CAD, conventional neuroimaging measures only partially explain the effect of CAD on cognition. The purpose of this study was to determine if WM microstructural integrity and CAD using diffusion tensor imaging (DTI) correlates with cognitive function in older adults with CAD. METHODS: Forty-nine CAD patients (66 ± 7 years old, 86% male) underwent neurocognitive assessments using the cognitive battery recommended by the National Institute of Neurological Disorders and Stroke-Canadian Stroke Network for the study of vascular cognitive impairment. Composite scores for each cognitive domain were calculated. Microstructural integrity in normal-appearing WM was quantified as fractional anisotropy (FA) using DTI in nine bilateral and two interhemispheric WM tracts from the Johns Hopkins University WM Tractography Atlas. Linear regression models examined associations between FA and cognitive performance, controlling for age, sex, and education, with correction for multiple comparisons using a false discovery rate of 5%. RESULTS: Executive function was most significantly associated with FA in the left parahippocampal cingulum (β = 0.471, t = 3.381, df = 44, p = 0.002) and left inferior fronto-occipital fasciculus (β = 0.430, t = 2.984, df = 44, p = 0.005). FA was not associated with memory in any of the WM tracts examined. CONCLUSION: These results suggest that WM microstructural integrity may be an important neural correlate of executive function even in cognitively intact CAD patients. This study suggests WM damage may be relevant to subtle cognitive decline in a population that may have early neural risk for dementia.
OBJECTIVE:Coronary artery disease (CAD) is associated with an increased risk of cognitive decline. Although cerebral white matter (WM) damage predicts cognitive function in CAD, conventional neuroimaging measures only partially explain the effect of CAD on cognition. The purpose of this study was to determine if WM microstructural integrity and CAD using diffusion tensor imaging (DTI) correlates with cognitive function in older adults with CAD. METHODS: Forty-nine CAD patients (66 ± 7 years old, 86% male) underwent neurocognitive assessments using the cognitive battery recommended by the National Institute of Neurological Disorders and Stroke-Canadian Stroke Network for the study of vascular cognitive impairment. Composite scores for each cognitive domain were calculated. Microstructural integrity in normal-appearing WM was quantified as fractional anisotropy (FA) using DTI in nine bilateral and two interhemispheric WM tracts from the Johns Hopkins University WM Tractography Atlas. Linear regression models examined associations between FA and cognitive performance, controlling for age, sex, and education, with correction for multiple comparisons using a false discovery rate of 5%. RESULTS: Executive function was most significantly associated with FA in the left parahippocampal cingulum (β = 0.471, t = 3.381, df = 44, p = 0.002) and left inferior fronto-occipital fasciculus (β = 0.430, t = 2.984, df = 44, p = 0.005). FA was not associated with memory in any of the WM tracts examined. CONCLUSION: These results suggest that WM microstructural integrity may be an important neural correlate of executive function even in cognitively intact CAD patients. This study suggests WM damage may be relevant to subtle cognitive decline in a population that may have early neural risk for dementia.
Authors: Cassandra L Brown; Annie Robitaille; Elizabeth M Zelinski; Roger A Dixon; Scott M Hofer; Andrea M Piccinin Journal: Psychol Aging Date: 2016-12
Authors: Di Yu; Marie Hennebelle; Demetrios J Sahlas; Joel Ramirez; Fuqiang Gao; Mario Masellis; Hugo Cogo-Moreira; Richard H Swartz; Nathan Herrmann; Pak Cheung Chan; Jacqueline A Pettersen; Donald T Stuss; Sandra E Black; Ameer Y Taha; Walter Swardfager Journal: Transl Stroke Res Date: 2018-11-15 Impact factor: 6.829
Authors: Yelena Slinin; Tien Vo; Brent C Taylor; Anne M Murray; John Schousboe; Lisa Langsetmo; Kristine Ensrud Journal: Int J Geriatr Psychiatry Date: 2017-03-22 Impact factor: 3.485
Authors: Lauren E Salminen; Peter R Schofield; Kerrie D Pierce; Steven E Bruce; Michael G Griffin; David F Tate; Ryan P Cabeen; David H Laidlaw; Thomas E Conturo; Jacob D Bolzenius; Robert H Paul Journal: Behav Brain Res Date: 2017-04-27 Impact factor: 3.332
Authors: Walter Swardfager; Hugo Cogo-Moreira; Mario Masellis; Joel Ramirez; Nathan Herrmann; Jodi D Edwards; Mahwesh Saleem; Parco Chan; Di Yu; Sean M Nestor; Christopher J M Scott; Melissa F Holmes; Demetrios J Sahlas; Alexander Kiss; Paul I Oh; Stephen C Strother; Fuqiang Gao; Bojana Stefanovic; Julia Keith; Sean Symons; Richard H Swartz; Krista L Lanctôt; Donald T Stuss; Sandra E Black Journal: Neurology Date: 2018-01-26 Impact factor: 9.910
Authors: Yin Ting Cheung; Michelle N Edelmann; Daniel A Mulrooney; Daniel M Green; Wassim Chemaitilly; Neena John; Leslie L Robison; Melissa M Hudson; Kevin R Krull Journal: Cancer Epidemiol Biomarkers Prev Date: 2016-06-26 Impact factor: 4.254
Authors: Kasra Moazzami; Samaah Sullivan; Bruno B Lima; Jeong Hwan Kim; Muhammad Hammadah; Zakaria Almuwaqqat; Amit J Shah; Ihab Hajjar; Felicia C Goldstein; Allan I Levey; J Douglas Bremner; Arshed A Quyyumi; Viola Vaccarino Journal: J Psychosom Res Date: 2020-12-25 Impact factor: 3.006
Authors: Priya Palta; Michelle C Carlson; Rosa M Crum; Elizabeth Colantuoni; A Richey Sharrett; Sevil Yasar; Richard L Nahin; Steven T DeKosky; Beth Snitz; Oscar Lopez; Jeff D Williamson; Curt D Furberg; Stephen R Rapp; Sherita Hill Golden Journal: J Gerontol A Biol Sci Med Sci Date: 2017-12-12 Impact factor: 6.053